Blue Cross Blue Shield of North Carolina demanded another review of an already-approved, externally-reviewed IVIG infusion—48 hours before treatment. For a patient with life-threatening hypersensitivity reactions. This is how the denial machine works, and how one patient fought back and won.

Prior authorization delays cancer care and drives preventable deaths. Oncologists report treatment denials disease progression and ER visits caused by insurer delays. What began as medical review now functions as weaponized paperwork that outlasts patients.